Content Library | Clinical Trial Supply Forum

The clinical trials landscape is evolving rapidly—driven by innovative technologies, shifting patient needs, and a strong push for global inclusion. In this exclusive interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how clinical trial supply chains are being reshaped by new challenges and opportunities. From the rise of AI and automation to the shift towards decentralised, patient-centric trials, Steve offers valuable insights on how the industry can not only adapt but thrive.

Discover how embracing cutting-edge technology, reinforcing data integrity, and championing sustainability will future-proof clinical operations in a complex, diverse world.

Download the interview to learn more about:

• AI & Automation: Revolutionising trials by speeding up development, boosting efficiency, and enhancing data quality.
• Decentralisation & Patient-Centric Models: Elevating trial operations through improved enrolment and retention.
• Sustainability & Global Inclusion: Integrating greener practices while ensuring accessibility for diverse populations.
  

The future of clinical trials is unfolding—join this transformative journey today!

Navigating the evolving landscape of clinical trial supply chain regulations is a continuous challenge for pharmaceutical companies, CROs, and solution providers. With shifting compliance requirements across the EU, UK, and US, staying ahead of regulatory updates is essential for seamless trial execution and patient safety.

This Fact Sheet breaks down the complexities of global clinical trial supply regulations, providing actionable insights to help CTS professionals mitigate risks, ensure compliance, and build resilient, patient-centric supply chains and includes expert insights from Kamal Amin, Head of Supply Management, Galderma and Steven Jacobs, President, Global BioPharm Solutions, LLC.

Download to learn more about:

• Regulatory Updates & Compliance: Understanding the latest changes in GDP, GMP, EU CTR, ICH E6 (R3), MDR, post-Brexit UK regulations, and FDA guidelines.
• Risk Mitigation Strategies: Identifying potential regulatory risks and implementing proactive compliance measures.
• Supply Chain Resilience: Developing strategies to enhance flexibility and stability in an evolving regulatory environment.
• Sustainability in Clinical Supply: Exploring global initiatives to integrate sustainability into supply chain operations.
• Patient-Centric Supply Chains: Ensuring timely and compliant delivery of trial materials to improve patient outcomes.

Stay informed and prepared—download this fact sheet today to optimise your supply chain strategy in an increasingly complex regulatory environment.

The clinical trial supply chain is undergoing a radical transformation. With the complexity of multi-indication treatments and rare disease trials driving new challenges, innovative technologies and strategies are now essential. In this interview, Steve Jacobs, President of Global BioPharm Solutions, LLC, explains how advanced tools and patient-centric approaches are reshaping every link in the supply chain.

Steve discusses how AI, automation, and digital tools are streamlining operations—from accurate forecasting and data collection to efficient drug returns and reconciliation. These innovations not only boost efficiency and data quality but also help overcome challenges like supply kit expiries and comparator shortages. He also highlights the benefits of decentralised, direct-to-patient models that improve enrolment and retention while ensuring regulatory compliance and sustainability.

Download this interview to learn more about:

• Transforming Clinical Supply Chains: AI and automation streamline data collection, enhance forecasting accuracy, and reduce manual inefficiencies to ensure timely supplies and improved operational performance.
• Decentralised Trials & Direct-to-Patient Models: Direct-to-patient approaches address recruitment challenges and complex multi-indication studies, elevating enrolment, retention, and overall supply chain effectiveness.
• Integrated Systems & Sustainability: Scalable, eco-friendly systems overcome packaging, regulatory, and drug return challenges while ensuring global access and robust data integrity.

Embrace the future of clinical trial supply management where cutting-edge technology meets smart, sustainable strategy.

Join us to collaborate with senior industry leaders to successfully build a supply chain that is agile, sustainable and built around patient needs. 

Are you wondering who you will meet at the event? Download our Sample 2025 attendee list and find out.

Present your boss with this customizable letter detailing the reasons why you should attend Clinical Trial Supply Forum 2025 from 13 – 15 May, 2025 in Brussels, Belgium. Just download the letter template below, adjust as necessary (or edit as needed) and submit! We hope to welcome you there!

In an era where clinical trials are becoming increasingly complex and global, developing a robust supply strategy is more critical than ever. This strategic framework is designed to help you navigate the complex landscape of clinical trial supply, offering a step-by-step approach to crafting a resilient and adaptable strategy.

The pharmaceutical sector loses billions of dollars annually due to logistical failures including temperature excursions and a lack of end-to-end visibility. The rapid shipment of vaccines worldwide to tackle Covid-19 highlighted the need for transport containers that adequately protect the medicines they are delivering. Since the pandemic began in 2020, additional factors such as a rise in demand for temperature-sensitive medicines, natural disasters and geopolitical factors have led to greater risk throughout supply chains, making them more vulnerable than ever before.

The clinical trial supply industry is going through a period of rapid change, propelled by the aftermath of the pandemic and the rapid evolution of technology. Additionally, world-changing geopolitical events continue to impact supply chains across all sectors. Pharma IQ interviewed Advisory Board member and Event Chairman, Steven Jacobs, President of Global BioPharm Solutions LLC, and we are pleased to take this opportunity to share with you our annual review of the trends and complexities that are shaping and driving transformation across the -end-to-end clinical trial supply chain.

Download the Report to Uncover:

• Expert Analysis on Industry Evolution: Gain invaluable insights into the profound transformation of the clinical trial supply landscape, emphasising the shift towards proactive, strategic supply chain models and the integration of cutting-edge technologies like AI and IoT.

• Impact of Global Challenges on Supply Chains: Learn how recent geopolitical events and the aftermath of the pandemic have driven innovation, emphasising the need for resilience and agility in overcoming supply chain disruptions.

• Technological Advancements in Supply Management: Explore the role of digital transformation in revolutionising supply chain management, with a focus on automation, predictive analytics, and real-time decision-making to ensure the success and integrity of clinical trials.

• Sustainability and Efficiency as Core Priorities: Delve into the growing emphasis on eco-friendly logistics and the optimisation of resource use, highlighting sustainable practices and efficiency improvements as key drivers of future industry success.

Alexandra Tsioni, Associate Director, Clinical Supply Chain Global Lead, Israel, brilliantly presented a 'Direct-to-Patient Case Study' at the Clinical Trial Supply Forum 2022. 

Download your copy to learn more about: 

• The impact of COVID-19 on clinical trials 
• Direct-to-patient vs traditional approaches 
• The impact on clinical supplies 
• Direct-to-patient case study considerations, challenges and mitigations

Discover the key highlights and learnings from the 2023 Clinical Trial Supply Forum in a concise, informative infographic format and understand what's shaping the future of the clinical trial supply industry. 

Building reverse logistics and product reconciliations into your supply strategy to optimise end to end distribution management was delivered at the Clinical Trial Supply Forum 2022 by Kamal Amin, Head of Supply Management, Galderma.

Download your copy to view:

• The role of clinical supplies teams within the reverse logistics and reconciliations management strategy 
• Where your returns and reconciliations fit into your end-to-end clinical supply lifecycle
• Ways to reduce unforeseen costs through flexible product return and destruction strategies 
• End-to-end alignment in supply management by effectively engaging your clinical teams across the process implementation lifecycle 

In the realm of clinical trials, patient recruitment poses a significant challenge, with merely 2%-5% of U.S. patients currently engaged in these crucial research endeavors. Patients represent the cornerstone of any clinical trial, without whom progress in developing novel therapies and advancing care innovation would stall. Consequently, ensuring patient participation and completion stands as a primary focus for clinical trial sponsors. While extensive research has been dedicated to understanding barriers to participation, such as access and indirect expenses like travel and lodging, another critical factor hindering participation and exacerbating patient drop-out emerges: the coverage of care for baseline or comparator drugs in the U.S., which contrasts with other countries like the U.K. where sponsors typically bear such costs. This disparity in coverage may disproportionately impact socio-economically vulnerable and diverse patient populations, potentially impeding their access to and engagement in vital clinical trials.

Dive into the whitepaper today to explore:

• The current state of care coverage in cancer trials
• Developing a framework to understand sponsor coverage impact
• Cost of noncoverage versus cost of coverage
• A case for coverage

The Clinical Trial Supply Forum (13-15 May, 2025 in Brussels, Belgium) is a platform where Clinical Trial Supply professionals on all seniority levels gather to exchange exclusive insights, establish valuable connections and collaboratively tackle industry challenges. 

Are you interested in seeing who you will meet at Clinical Trial Supply Forum 2025? Download our current attendee list today.

Are you interested in sponsoring Clinical Trial Supply Forum 2025? Download our 2025 prospectus and see how you can be a part of our event. We have a variety of flexible sponsorship packages, designed to align with your unique goals.